Edesa Biotech, Inc.
EDSA
$1.96
-$0.075-3.69%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 31.37% | -2.40% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -13.68% | 89.04% | |||
| Operating Income | 13.68% | -89.04% | |||
| Income Before Tax | 1.71% | -68.10% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1.66% | -68.10% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.66% | -68.10% | |||
| EBIT | 13.68% | -89.04% | |||
| EBITDA | 13.00% | -89.95% | |||
| EPS Basic | 37.99% | -63.23% | |||
| Normalized Basic EPS | 46.04% | -86.38% | |||
| EPS Diluted | 37.99% | -63.23% | |||
| Normalized Diluted EPS | 46.04% | -86.38% | |||
| Average Basic Shares Outstanding | 58.61% | 3.00% | |||
| Average Diluted Shares Outstanding | 58.61% | 3.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||